News & Insights
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
Filters
Filters
Therapeutic Areas
In Vivo AI Platforms
Mental Illness
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain
Sleep & Seizure Disorders
Rare CNS Disorders
Traumatic Brain Injury
Specific Disorders
Apply Filters
Filters
PUBLICATION
Behavior-based screening as an approach to polypharmacological ligands.
November 29, 2011
PUBLICATION
HD Mouse Models reveal clear Deficits in Learning to Perform a Simple Instrumental Response. PLoS Currents: Huntington Disease.
November 14, 2011
PUBLICATION
Discovery of Isoxazole Analogs of Sazetidine-A as Selective alpha4 beta2-Nicotinic Acetylcholine Receptor (nAChR) Partial Agonists for the Treatment of Depression,
June 29, 2011
PUBLICATION
Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration,
June 28, 2011
PUBLICATION
Effect of the rd1 mutation on motor performance in R6/2 and wild type mice [Internet]. Version 28.
March 15, 2011
PUBLICATION
Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat
March 14, 2011
PUBLICATION
Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms.
March 10, 2011
PUBLICATION
Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.
March 5, 2011
PUBLICATION
Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats.
February 20, 2011